Solid Biosciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $104,315,000.

Profit Margin

Solid Biosciences Inc. (NASDAQ:SLDB): Profit margin
2015 0 -6.37M
2016 0 -21.53M
2017 0 -52.11M
2018 0 -74.79M
2019 0 -115.64M
2020 0 -90.11M
2021 13.62M -72.12M -529.54%
2022 8.09M -65.51M -809.36%
2023 0 -96.01M

SLDB Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
08.09M13.62M000000
Cost of revenue
76.56M2.40M58.73M3.92M2.82M0448K00
Gross profit
-76.56M5.68M-45.11M-3.92M-2.82M0-448K00
Operating exp.
Research and development
76.56M78.42M58.73M64.88M94.73M57.96M39.90M20.11M4.19M
Selling and marketing
000000000
Total operating expenses
104.31M107.36M85.87M86.46M119.31M75.68M54.85M25.57M6.56M
Operating income
-104.31M-106.45M-72.25M-88.40M-119.31M-75.68M-54.85M-25.57M-6.56M
Other income (expenses), net
8.3M20.47M66K-1.82M2.09M270K1.67M1.43M-100K
Income before tax
-96.01M-85.98M-72.18M-88.29M-117.22M-74.79M-53.17M-23.77M-6.66M
Income tax expense
0-20.47M-64K1.82M-1.58M889K-1.27M-2.60M-287K
Net income
-96.01M-65.51M-72.12M-90.11M-115.64M-74.79M-52.11M-21.53M-6.37M
Earnings per share
Basic EPS
-4.83-7.7-10.13-26.03-43.05-33.73-24.26-16.8-4.97
Diluted EPS
-4.83-7.7-10.13-26.03-43.05-33.73-24.26-16.8-4.97
Data sourceData sourceData sourceData sourceData sourceData sourceData source